KCNIP4
Basic information
Region (hg38): 4:20728606-21948772
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the KCNIP4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 5 | |||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 3 | 3 | ||||
non coding | 1 | |||||
Total | 0 | 0 | 7 | 0 | 1 |
Variants in KCNIP4
This is a list of pathogenic ClinVar variants found in the KCNIP4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-20749655-A-G | KCNIP4-related disorder | Benign (Oct 16, 2019) | ||
4-20749681-T-C | not specified | Uncertain significance (Dec 15, 2022) | ||
4-20758859-G-T | not specified | Uncertain significance (Dec 26, 2023) | ||
4-20758897-A-G | Benign (Dec 31, 2019) | |||
4-20850543-A-G | KCNIP4-related disorder | Benign (Oct 18, 2019) | ||
4-20850608-G-A | not specified | Uncertain significance (Mar 25, 2024) | ||
4-20850621-A-G | KCNIP4-related disorder | Benign (Oct 18, 2019) | ||
4-20850662-C-T | not specified | Uncertain significance (Nov 17, 2022) | ||
4-20850664-C-T | not specified | Uncertain significance (Mar 08, 2024) | ||
4-20882649-A-G | not specified | Uncertain significance (Feb 26, 2024) | ||
4-21697422-T-A | Uncertain significance (Feb 01, 2019) | |||
4-21948616-C-T | not specified | Uncertain significance (Oct 29, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
KCNIP4 | protein_coding | protein_coding | ENST00000382152 | 9 | 1220184 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.821 | 0.179 | 125704 | 0 | 3 | 125707 | 0.0000119 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.39 | 94 | 140 | 0.669 | 0.00000754 | 1688 |
Missense in Polyphen | 24 | 50.672 | 0.47364 | 635 | ||
Synonymous | 0.0220 | 49 | 49.2 | 0.996 | 0.00000288 | 429 |
Loss of Function | 3.03 | 2 | 14.4 | 0.139 | 6.10e-7 | 182 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000628 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000177 | 0.0000176 |
Middle Eastern | 0.0000628 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Regulatory subunit of Kv4/D (Shal)-type voltage-gated rapidly inactivating A-type potassium channels. Modulates KCND2 channel density, inactivation kinetics and rate of recovery from inactivation in a calcium-dependent and isoform-specific manner (PubMed:11847232, PubMed:18957440, PubMed:23576435). Modulates KCND3/Kv4.3 currents (PubMed:23576435). Isoform 4 does not increase KCND2 expression at the cell membrane (PubMed:18957440). Isoform 4 retains KCND3 in the endoplasmic reticulum and negatively regulates its expression at the cell membrane. {ECO:0000250|UniProtKB:Q6PHZ8, ECO:0000269|PubMed:11847232, ECO:0000269|PubMed:18957440, ECO:0000269|PubMed:23576435}.;
- Pathway
- Phase 1 - inactivation of fast Na+ channels;Cardiac conduction;Muscle contraction;Regulation of nuclear beta catenin signaling and target gene transcription
(Consensus)
Intolerance Scores
- loftool
- rvis_EVS
- -0.34
- rvis_percentile_EVS
- 30.07
Haploinsufficiency Scores
- pHI
- 0.371
- hipred
- Y
- hipred_score
- 0.641
- ghis
- 0.590
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.943
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Kcnip4
- Phenotype
Gene ontology
- Biological process
- potassium ion transmembrane transport;protein localization to plasma membrane;regulation of potassium ion transmembrane transport
- Cellular component
- cytoplasm;endoplasmic reticulum;cytosol;plasma membrane;voltage-gated potassium channel complex
- Molecular function
- voltage-gated ion channel activity;potassium channel activity;calcium ion binding;protein binding;potassium channel regulator activity